This report was commissioned by the Norwegian Institute of Public Health and focused on the political feasibility of an international agreement on antimicrobial resistance. The major finding was that a comprehensive response to AMR would commit all countries to act simultaneously on access, conservation and innovation. However, such an agreement is not immediately politically feasible without additional incentives and supports; instead a core groups of specialized countries could act to create the basis of an agreement before inviting other countries to join.
This report provides options for navigating five key issues faced by humanitarian organizations when responding to an epidemic: training, communication of risk, insurance, medical evacuation and reintegration. Options focus on practices that a humanitarian organization ought to adopt when interacting with its employees, since employees are owed a legal duty of care that, when ignored, makes an organization vulnerable to legal action. The options were identified by studying the successes and shortcomings of the Ebola response, and are meant to equip humanitarian organizations with the tools necessary to respond to future epidemics in a way that is efficient and that mitigates their liability.
This report explores a number of drug development and delivery models for the Canadian government to consider implementing as it looks to improve access to essential medicines both domestically and internationally.The Office ofInternational Affairs for the Health Portfolio (OIA-HP) commissioned the research of four market-level case studies, which focus on innovative financing and collaborative initiatives, and one patient-level case study, which considers international legislation as a model to improve Canada’s purchasing power. The Innovative Medicines Initiative (IMI), the International Finance Facility for Immunization (IFFIm), Open Source Drug Discovery (OSDD), Drugs for Neglected Diseases Initiative (DNDi), and Australia’s Pharmaceutical Benefits Scheme (PBS) were specifically selected based on their relevance to Canada’s strong pharmaceutical industry, commitment to R&D and global aid, and domestic health needs.
Mental health issues pose critical challenges for Canada's systems of justice and health care. Problems with mental health are common, but often neglected due to stigma and the vulnerability of those living with these conditions. This is evident within our legal system. Every day in our courts we see played out the struggle to protect the human rights and dignity of individual Canadians with mental health challenges, to access adequate mental health care and social support, and to provide genuinely helpful responses to criminal behaviour associated with mental health problems. Law and Mind: Mental Health Law and Policy in Canada provides a comprehensive analysis of the most important cases and key debates at the intersection of mental health law and policy.
Written by a group of Canada's leading experts on mental health law, this volume provides practitioners, researchers and policy-makers with valuable insight into this challenging and important area of the law.
Features and benefits Law and Mind: Mental Health Law and Policy in Canada is an important resource for understanding the complexities of mental health law and related policy issues in Canada.
Law students, practising lawyers and policy-makers alike will benefit from the broad range of topics covered in this comprehensive text. Topics addressed include the law surrounding the funding and administration of mental health care in Canada, the principles of mental health law related to hospitalization and consent to treatment, the components of the criminal law of mental disorder, and mental health issues in the policing and correctional contexts. In addition, the authors offer focused treatment of mental health law issues facing specific populations, including children, the elderly, refugees and ethnic minorities.
This text is written by leading mental health law experts who bring years of practice, research and expertise to provide readers with a comprehensive resource which:
Presents the legal issues related to mental health in a comprehensive manner
Enables students and lawyers to learn this challenging subject matter quickly and effectively
Analyzes recent changes and developments in the law
Provides current information so lawyers can properly advise their clients
Discusses pressing and emerging mental health issues that are relevant to practitioners and their clients
Essential reading This new release will be particularly useful for:
Health lawyers advising clients and in-house lawyers at health service providers as it is an up-to-date resource on mental health law and policy
Students looking for a comprehensive resource on mental health law written by leading academics
Government health workers and policymakers who need to consult a reliable reference volume
Law libraries that want to stock essential guides for lawyers and students
Antimicrobial resistance (AMR) is a global health concern that poses a serious threat to the control of infectious disease. A continuous increase in rates of AMR poses a challenge to the global community and impedes progress previously made in improving health outcomes. This report examines how AMR can be addressed using international instruments, and the appropriate role of the World Health Organization (WHO) in this task. It is recommended that global collective action on AMR be achieved by implementing a Treaty under Article 19 and a Regulation under Article 21 of the WHO’s Constitution. This suite of international instruments can be used to address the greatest proportion of issues that currently impede AMR’s resolution and can mobilize the most effective action. This report further establishes that the WHO has legal authority under its Constitution to create these international instruments to address AMR.
This paper finds that some functions in the global health system are performed by a greater concentration of actors than others, which may not be the best configuration to match the future challenges that the global health system will face.
The purpose of this working paper is to explore the feasibility of compiling and synthesizing disease‐specific information to inform the deliberation and discourse on identifying priorities for research to improve health – with a specific focus on the dimensions of public health, implementation science and financing. This working paper is a companion to Working Paper 1, which focused on basic science and targeted product development, including diagnostics, drugs, vaccines, microbicides and vector control products [Working Paper 1: “Priority Research Areas for Basic Science and Product Development for Neglected Diseases” by Sue J. Goldie, Jennifer S. Edge, Christen Reardon, Cherie L. Ramirez].
Health systems research is widely recognized as essential for strengthening health systems, getting costeffective treatments to those who need them, and achieving better health status around the world. However, there is significant ambiguity and confusion in this field’s characteristics, boundaries, definition and methods. Adding to this ambiguity are major conceptual barriers to the production, reproduction, translation and implementation of health systems research relating to both the complexity of health systems and research involving them. These include challenges with epistemology, applicability, diversity, comparativity and priority-setting. Three promising opportunities exist to mitigate these barriers and strengthen the important contributions of health systems research. First, health systems research can be supported as a field of scientific endeavour, with a shared language, rigorous interdisciplinary approaches, cross-jurisdictional learning and an international society. Second, national capacity for health systems research can be strengthened at the individual, organizational and system levels. Third, health systems research can be embedded as a core function of every health system. Addressing these conceptual barriers and supporting the field of health systems research promises to both strengthen health systems around the world and improve global health outcomes.
gstrategylabHow to change systems for global health leadership? Stems from organizational change, and individual change... GSL’s team is learning about systems change and design thinking at #WLGH18 parallel panels today!! t.co/2ADtAi0vIj